DGAP-News: EDMOND DE ROTHSCHILD INVESTMENT PARTNERS SELLS

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: EDMOND DE ROTHSCHILD INVESTMENT PARTNERS SELLS ITS POSITION IN COVAGEN AG TO JANSSEN AFFILIATE CILAG GMBH INTERNATIONAL, A JOHNSON & JOHNSON COMPANY

DGAP-News: Edmond de Rothschild Investment Partners / Key word(s): Investment EDMOND DE ROTHSCHILD INVESTMENT PARTNERS SELLS ITS POSITION IN COVAGEN AG TO JANSSEN AFFILIATE CILAG GMBH INTERNATIONAL, A JOHNSON & JOHNSON COMPANY 25.08.2014 / 15:15 --------------------------------------------------------------------- EDMOND DE ROTHSCHILD INVESTMENT PARTNERS SELLS ITS POSITION IN COVAGEN AG TO JANSSEN AFFILIATE CILAG GMBH INTERNATIONAL, A JOHNSON & JOHNSON COMPANY This operation is the fifth trade sale of BioDiscovery 3, the thirteenth from BioDiscovery fund Edmond De Rothschild Investment Partners (EdRIP) announced today that a BioDiscovery 3 portfolio company, Covagen A.G., has been acquired by Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Company which belongs to the Johnson & Johnson Family of Companies. Covagen is a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb(R) technology platform. The company's lead product, COVA322, a bispecific anti-tumor necrosis factor (TNF)-alpha/anti-interleukin (IL)-17A FynomAb is in Phase 1b study for psoriasis and holds potential as a treatment for a broad range of inflammatory diseases including rheumatoid arthritis. Covagen develops FynomAbs, multi-specific protein therapeutics by fusing its fully human Fynomer binding proteins to antibodies. Fynomers are small binding proteins engineered to bind to target molecules with the same affinity and specificity as antibodies. The tailored architecture and novel mode of action of FynomAb therapeutics may offer enhanced efficacy in the treatment of inflammatory diseases and other indications. "A few years back we decided to invest in Covagen based on the quality of the team and the versatility and flexibility of their Fynomer technology. Since then, impressive progress has been made and today we are very proud to see a highly respected partner taking over the development of the lead product and the FynomAb platform. After achieving a high investment multiple, we are looking forward to seeing them translate all this potential into next-generation products that can improve patient outcomes," said Gilles Nobécourt, Partner at Edmond de Rothschild Investment Partners. Covagen was the eighth investment of BioDiscovery 3, a specialized life science investment fund managed by EdRIP. Raised in 2008, the Fund has invested from 2008 to 2012 in a portfolio of 14 companies. So far five of these companies have been sold through private transactions and two have been listed on public financial markets. About Edmond de Rothschild Investment Partners Edmond de Rothschild Investment Partners is the private equity affiliate of the Edmond de Rothschild Group, which is specialized in asset management and private banking (EUR 133.6bn under management, nearly 2,800 employees spread across 31 offices, branches and subsidiaries throughout the world). Founded in 1953, the Group has been chaired since 1997 by Baron Benjamin de Rothschild. Paris-based Edmond de Rothschild Investment Partners is dedicated to minority investments into privately-owned companies. It currently has more than EUR1 billion under management which is being invested primarily as life sciences venture capital and growth capital. Within Edmond de Rothschild Investment Partners, its Life Sciences Team of eight professionals brings together over 60 years of experience in the Life Science industry and more than 100 years of private equity and venture capital experience. The Team has raised EUR450 million through its Biodiscovery franchise and is currently investing BioDiscovery 4. Since inception, BioDiscovery Funds have invested in 49 companies, of which 13 have been sold and 12 listed on public financial markets. 19 are still active in the portfolios. BioDiscovery Funds, including BioDiscovery 4, are venture capital funds dedicated to professional investors. These funds are not authorized by the Autorité des Marchés Financiers and may adopt special investment rules. For more information : www.edrip.fr Contacts Edmond de Rothschild Investment Partners Gilles Nobécourt g.nobecourt@edr.com Tel: +33 1 40 17 27 69 --------------------------------------------------------------------- 25.08.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- 283775 25.08.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CSMI Keeps Command Vehicles Ready for DHS Ops

Updated Category News Views 7

CSMI Secures Critical DHS FPS Contract There's something gritty when a small outfit like CSMI lands a deal that keeps rolling the gears of national security machinery. CSMI, LLC, headquartered in Salem, New Hampshire, has snagged a recompete contract to provide Operations and Maintenance support for the Department of Homeland Security's (DHS) Federal Protective Service...

Continue Reading
Sivers Semiconductors Shakes Up Auditors and Incentives

Updated Category News Views 5

Rethinking the Auditing Game Well, what do you know? Sivers Semiconductors just gave the boot to Deloitte AB. Looks like they're rolling out the welcome mat for Ernst & Young AB to scrutinize their books instead. The move, coming hot from the Extraordinary General Meeting, shows they're not messing around with their financial oversight. Maybe it's a bid for fresh...

Continue Reading
When Families Should Consider Life Insurance Plans

Updated Category News Views 4

Let’s talk about why life insurance isn’t just for those walking around with gray hair. K.D. the Insurance Queen from Centennial, Colorado, dishes out the clearest advice on when and why families ought to have it in their arsenal. A New Mindset on Life Insurance Some folks out there think life insurance is something you ponder in your twilight years. But here’s the...

Continue Reading
Rentvine Unleashes AI Innovations in Property Management

Updated Category News Views 10

Rentvine's Leap in AI Technology Right off the bat, let's give these guys some due credit. Rentvine, located in Bonita Springs, is tearing through the property management software scene like a train on rocket fuel. They just rolled out a suite of AI tools that's shaking up the single-family rentals management industry. During NARPM National in Las Vegas, they showcased...

Continue Reading
ThreatLocker Launches Global AI Awareness Campaign

Updated Category News Views 3

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Continue Reading
TruGolf's E6 Golf Platform Hits 15,000 Courses Milestone

Updated Category News Views 5

E6's Expanding Universe of Courses TruGolf's E6 is swinging big with a library that's breaking records—more than 15,000 real-world golf courses now available on demand. It's a leap of 50% in under a year, an impressive stride for any tech-driven platform, golfing or otherwise. The magic behind this growth? On-demand generation, allowing the software's library to expand...

Continue Reading
Rising Rates and War in Iran Hit Investor Nerves

Updated Category News Views 8

An Unsettling Mix for Real Estate Investors The latest RCN Capital Investor Sentiment Survey reveals a shaky real estate landscape, plagued by a mix of geopolitical conflict and central bank policy changes. You know you're in trouble when investor sentiment just crawls back from an all-time low, bouncing barely from an index score of 84 to 89. It's the kind of timid...

Continue Reading
QFIN Investors Eye Class Action Amid Regulatory Struggles

Updated Category News Views 3

QFIN Shareholders Unite Amid Regulatory Storm It's not every day you see a stock nosedive by nearly 19% overnight. But when you're investing in a company like Qfin Holdings, you get ready for a wild ride, especially when regulatory changes from China come into play. That's exactly what's happening right now as investors rally around a class action lawsuit against Qfin....

Continue Reading
Qingdao's Food Trade Triumph at SIAL Paris Booms

Updated Category News Views 3

Qingdao Impresses in the Global Food Arena Well, 2026 is serving up something special from Qingdao. During SIAL Paris, everyone's talking about how Qingdao’s food companies smashed expectations with 82 million yuan in intended orders. You’ve got CCPIT Qingdao pulling the strings, setting up an exhibition platform that was nothing short of top-tier. Staging a Show at...

Continue Reading
Lyric Health's Grace: Transforming Virtual Healthcare

Updated Category News Views 10

Grace in the Spotlight: A Game-Changer in Virtual Healthcare If you're tired of healthcare tech making big promises and delivering little, this might pique your interest. Lyric Health has rolled out Grace, a multimodal AI addition to their Virtual Care Operating System. This isn’t your run-of-the-mill chatbot — it’s a blend of proactive health monitoring,...

Continue Reading

Top 5 Most Recently Viewed Articles

NRx Pharmaceuticals Pushes for Benzethonium Chloride Removal

Updated Category News Views 153

NRx Pharmaceuticals Takes a Stand on Ketamine Safety In a significant move towards enhancing patient safety, NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) has filed a Citizen Petition with the U.S. Food and Drug Administration (FDA). This petition seeks the removal of Benzethonium Chloride, a preservative not recognized as safe, from all ketamine products. This action...

Continue Reading
Unlocking BYUSDT: Bybit's New Retail Transactions Feature

Updated Category News Views 125

BYUSDT Now Available for All Bybit Users Bybit, recognized as the world's second-largest cryptocurrency exchange by trading volume, recently announced an exciting new feature named BYUSDT. This service is now officially available for eligible Bybit users, providing an innovative way to combine trading and yield earning capabilities. Previously, access to BYUSDT was...

Continue Reading
Major Cash Payment Received for Duquesne West Project Advancements

Updated Category News Views 128

Significant Financial Milestone for Duquesne West Project Globex Mining Enterprises Inc. (TSX: GMX, Other OTC: GLBXF) is thrilled to announce a major financial achievement as Emperor Metals Inc. has remitted a substantial cash payment of $500,000 to Duparquet Assets Ltd. This payment marks the second-year cash portion of the Duquesne West option and reflects the positive...

Continue Reading
Primabolics Launches Innovative Health Solutions for US Market

Updated Category News Views 157

Primabolics Unveils New Horizons in Health Supplements Primabolics has made a lasting impact in the competitive wellness market in Australia by integrating traditional health practices with modern sports supplementation. The nutraceutical sector has been expanding rapidly, with estimates placing its value at over $590 billion in recent years. This market is poised to...

Continue Reading
UniFirst's Successful Financial Performance Report for 2024

Updated Category News Views 268

UniFirst Corporation Reports Strong Financial Results for 2024 Today, UniFirst Corporation (NYSE: UNF) released its financial results for the fourth quarter and the entire fiscal year of 2024. This news marks a significant milestone for the company, reflecting a successful year of growth and adaptation. The results encapsulate not just the numbers, but also the dedication...

Continue Reading